Typical of traders to rout the shares after another quarter of blow out numbers.
Everyone knows the street is spooked easily. Gilead was not clear on the HEP C sales for 2015, so the unknown is a fail. Also, it looks like the discounting is double what it was in 2014. Another fail.
I say whatever! All business expand and contract. It’s built into the normal sales cycle. The performance of GILD over the last 10 to 15 years is crazy good, so for long term holders, now is not a dump opportunity. For traders, who knows. For me, the R&D continues so the smile still shines.
SMZ
